Skip to main content
Clinical Trials/CTRI/2023/01/048858
CTRI/2023/01/048858
Not Yet Recruiting
Phase 4

Clinical and Dermoscopic evaluation to study the effectiveness of Metformin vs Pioglitazone in Acanthosis Nigricans - A Randomised Control Trial.

KLE Academy of Higher Education and Research - KLE University Grant0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
KLE Academy of Higher Education and Research - KLE University Grant
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
KLE Academy of Higher Education and Research - KLE University Grant

Eligibility Criteria

Inclusion Criteria

  • Adult patients (\>\=18 years) with acanthosis nigricans attending the outpatient department of dermatology in KLE Prabhakar Kore Hospital
  • Patients from whom written informed consent is obtained

Exclusion Criteria

  • Patients already taking any oral hypoglycemic drug.
  • Patient diagnosed as Type 1 Diabetes Mellitus
  • Patient diagnosed as Drug induced AN
  • Patients diagnosed as AN due to known malignancy
  • Pregnant and lactating mothers
  • Known allergic reaction to either Metformin or Pioglitazone
  • Contraindicated for taking metformin or Pioglitazone

Outcomes

Primary Outcomes

Not specified

Similar Trials